(Q46530266)

English

Brain accumulation of amyloid β protein visualized by positron emission tomography and BF-227 in Alzheimer's disease patients with or without diabetes mellitus

scientific article published on 10 June 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Brain accumulation of amyloid β protein visualized by positron emission tomography and BF-227 in Alzheimer's disease patients with or without diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

1 reference

based on heuristic

inferred from title

Alzheimer's disease

1 reference

based on heuristic

inferred from title

Nobuyuki Okamura

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

author name string

Naoki Tomita

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Katsutoshi Furukawa

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Manabu Tashiro

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Kaori Une

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Shozo Furumoto

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Ren Iwata

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Kazuhiko Yanai

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Yukitsuka Kudo

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Hiroyuki Arai

10

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

publication date

10 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Geriatrics and Gerontology International

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

13

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

215-221

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

describes a project that uses

positron emission tomography

1 reference

based on heuristic

inferred from title

The projected effect of risk factor reduction on Alzheimer's disease prevalence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Risk of dementia in diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

A look inside the diabetic brain: Contributors to diabetes-induced brain aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Diabetes, related conditions, and dementia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

How does diabetes accelerate Alzheimer disease pathology?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Diabetes is related to cerebral infarction but not to AD pathology in older persons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

MRI of the brain in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Recent advances in the development of amyloid imaging agents.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Advances in molecular imaging for the diagnosis of dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Geriatric medicine, Japanese Alzheimer's disease neuroimaging initiative and biomarker development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

A practical method to predict rate of cognitive decline in mild to moderate Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00880.X

21 January 2018

Identifiers

10.1111/J.1447-0594.2012.00880.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22680403

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46530266&oldid=2116282937"